Evidence map›Paper›PMID 37138902›Full record

ArticleACS catalysis2022

Site-Selective Amide Functionalization by Catalytic Azoline Engrafting.

Wyatt C Powell, Garrett E Evenson, Maciej A Walczak

Open access · greenAbstract read
In one paragraph

Article in ACS catalysis, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Synthesis of Serine Derived Oxazolines Using a Molybdenum Dioxide Catalyst.Organic syntheses; an annual publication of satisfactory methods for the preparation of organic chemicals · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Wyatt C PowellDepartment of Chemistry, University of Colorado, Boulder, Colorado 80309, United States.
Garrett E EvensonDepartment of Chemistry, University of Colorado, Boulder, Colorado 80309, United States.ORCID 0000-0002-9215-6349
Maciej A WalczakDepartment of Chemistry, University of Colorado, Boulder, Colorado 80309, United States.ORCID 0000-0002-8049-0817
University of Colorado Boulder · US

Funding

Synthesis and Chemical Biology of Thiopeptide AntibioticsR01GM138682 · NIGMS · UNIVERSITY OF COLORADO · PI WALCZAK, MACIEJ · 2021 to 2024
$1.4M
NIGMS NIH HHS R01 GM138682
6 · The paper itself

Abstract

Direct peptide and protein activation is a challenging transformation because of the stabilizing effect of the amide group. While enzymes can be considered as prototypical systems that have evolved to achieve high selectivity and specificity, small-molecule catalysts that functionalize the amide group may accommodate a much larger selection of substrates but currently remain scarce. Here, by combining the desired features from both catalytic regimes we designed an artificial cyclodehydratase, a catalytic system for the site-selective modification of peptides and natural products by engrafting heterocycles into their scaffolds. The catalytic system features a molybdenum(VI) center that was decorated with a sterically congested tripod ligand. The optimized catalyst can introduce azolines into small molecules, natural products, and oligopeptides with high efficiency and minimal waste. We further demonstrate the utility of the new protocol in the direct functionalization of a single amide group in the presence of up to seven other chemically similar positions and in the direct conversion of these groups into amines and thioamides. This new mechanistic paradigm may address an unmet need for a general method for the selective and sustainable functionalization of peptides and natural products.

Indexed as

azoleazolinemolybdenumpeptidessite-selective functionalization

Identifiers

PMID37138902
PMCPMC10153596
OpenAlexW4283034568

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.